Clinical trial
Compare the Efficacy of Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery: Follow-up Extension
NCT03987373 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Compare the Efficacy of Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery: Follow-up Extension
- Lead sponsor
- Ruijin Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 1, 2019
- Completion date
- June 15, 2021
- Enrollment
- 500 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
antiplatelet therapy, coronary artery bypass grafting